-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Globus Medical, Raises Price Target to $117

Benzinga·05/08/2026 11:15:31
Listen to the news
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $114 to $117.